STOCK TITAN

Nektar Management To Present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Nektar (NKTR) to present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on January 10, 2024. Webcast accessible via Nektar website.
Positive
  • None.
Negative
  • None.

SAN FRANCISCO, Jan. 3, 2024 /PRNewswire/ -- Nektar (Nasdaq: NKTR) management is scheduled to present at the upcoming 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 10, 2024 at 5:15 p.m. Pacific Time. The presentation and Q&A session will be accessible via a Webcast through a link posted on the Investor Events Calendar section of the Nektar website: https://ir.nektar.com/events-and-presentations/events. This webcast will be available for replay until February 9, 2024.

About Nektar

Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology and immunology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Contact:

For Investors:
Vivian Wu of Nektar Therapeutics
628-895-0661

For Media:
David Rosen of Argot Partners
(212) 600-1902
david.rosen@argotpartners.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nektar-management-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-in-san-francisco-ca-302025739.html

SOURCE Nektar Therapeutics

FAQ

When is Nektar presenting at the 42nd Annual J.P. Morgan Healthcare Conference?

Nektar is scheduled to present on January 10, 2024 at 5:15 p.m. Pacific Time.

Where can I access the webcast of Nektar's presentation?

The webcast will be accessible via a link on the Investor Events Calendar section of the Nektar website: https://ir.nektar.com/events-and-presentations/events.

Until when will the webcast be available for replay?

The webcast will be available for replay until February 9, 2024.

Nektar Therapeutics

NASDAQ:NKTR

NKTR Rankings

NKTR Latest News

NKTR Stock Data

336.03M
163.11M
0.82%
67.26%
1.28%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
SAN FRANCISCO

About NKTR

nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. nektar also partners with the top biopharmaceutical companies to bring new products to market. to date, nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.